Altria Market Tracker

Altria Trading Activity

• 🔥 Bullish Options Flow: Altria Group saw 19,443 calls traded, 5x expected volume, with a Put/Call Ratio of 0.21 and...

Trend alert for Altria's on! and ZYN: Regulatory and public health pressures mount on pouches.

• Tax expansion: Washington applies 95% tobacco tax...

Vaping boom signals tailwind for reduced-risk nicotine shift:

• Valued at $16.42B in 2024, hitting $38.27B by 2033
• Driven by health awareness,...

• Bullish options surge: 19,443 calls traded (5x expected), most active 4/10 weekly 70/68 strikes with 13,900 contracts; P/C ratio 0.21
  -...

Analyst Coverage & Stock Performance

• 🔥 Zacks Highlights Altria: Zacks Investment Ideas on April 6, 2026, features Altria alongside Verizon and...

PMI sharply underperforms Altria and sector: PM -4.79%, MO -0.70%, Food & Beverages -0.69%.

• Core trigger: US regulatory delays on ZYN nicotine...

Rising regional anti-tobacco efforts signal trend of restricting addictive nicotine systems, pressuring industry reduced-risk portfolios:

• Niagara...

Critical shift in child nicotine risks: Vape exposures in kids under 6 jumped 243% (2016-2023) from 92,000+ cases, overtaking cigarettes which fell...

In the booming oral nicotine pouch market, FRE differentiates with five clear strength options—3mg, 6mg, 9mg, 12mg, 15mg—offering more versatility...

Key highlights for tobacco investors:

• Dividend King status: Altria, with its leading U.S. tobacco portfolio (combustible and smoke-free), is a...

• Massive expansion ahead: E-cigarette/vape market hits $48.2B in 2026, surging to $255.3B by 2033 at 26.9% CAGR.
• Rivals lead the pack: Juul Labs,...

Emerging EU regulatory risk: 85% of Irish adults support an immediate ban on nicotine pouch sales to under-18s.

• Pouches (tobacco-free,...

Youth vaping persists at scale: 1.63 million middle/high school students used e-cigs in 2024, down from 2023 but still massive.

• Mostly illegal: Up...

Investor Holdings Shift

• 🔥 SteelPeak Trims Altria Stake: SteelPeak Wealth LLC cut its stake in Altria Group by 67.3% in Q4, selling 104,914...

Key Q4 institutional shifts signal nuanced sentiment for Altria:

• SteelPeak Wealth LLC slashed holdings 67.3%, selling 104,914 shares to end with...

Emerging evidence signals major challenges for nicotine vaping products (NVPs):

• Cancer links: Vaping causes DNA damage, inflammation, and lung...

Denver's ban on flavored nicotine products is embroiled in a continuing legal battle, signaling persistent local regulatory risks for nicotine industry compliance and market access.

Pediatric nicotine risks escalate as toddler exposures shift dramatically: traditional tobacco down 43%, e-cigarette cases up 243%.

• Inhalation...

US Anti-Nicotine Public Health Campaigns

• 🔥 California 'Not Your Lab Rat': California Department of Public Health launched the 'Not Your Lab...

Over the past 4 years, Australian tobacco makers continue releasing extra-long and slim cigarettes plus bonus cigarette packs, focused on mainstream and premium segments—highlighting resilient demand amid global regs.